Considerations for Pricing & Formulary Access for DRG-Funded Hospital Drugs Blog Considerations for Pricing & Formulary Access for DRG-Funded Hospital Drugs In the United States, treatments or medical services that require the patient be admitted into…Certara2023 年 4 月 6 日
Using Quantitative Systems Pharmacology Modelling to Accelerate Drug Development Article Using Quantitative Systems Pharmacology Modelling to Accelerate Drug Development Model informed drug development (in silico modelling) continues to be a game changer in accelerating…Certara2023 年 3 月 29 日
Model-Informed Drug Development (MIDD) – EMA’s Advancement Article Model-Informed Drug Development (MIDD) – EMA’s Advancement Modelling and simulation (M&S) plays a crucial role in drug development. It allows information from…Certara2023 年 3 月 29 日
Advancing Biopharmaceutics & Drug Formulation Using In Silico Modeling White Paper 运用计算机建模推动生物制药与药物制剂研发 模型引导的制剂开发(MIFD)提升新药与仿制药开发速度与确定性Danielle Pillsbury2023 年 3 月 22 日
Data-Backed Trial Design– Applying AI to Clinical Outcome Analysis On-Demand Webinar 数据支持的试验设计 — 将人工智能应用于临床结果分析 Global spending on clinical trials is expected to reach $68.9 billion per year by 2025…Danielle Pillsbury2023 年 3 月 17 日
eCTD Authoring Templates – A Springboard to Submission Success Fact Sheet eCTD Authoring Templates – A Springboard to Submission Success Danielle Pillsbury2023 年 3 月 17 日
Leveraging AI to Accelerate Drug Discovery: Vyasa Joins Certara Blog 利用人工智能加速药物发现:Vyasa 加入 Certara Applying Vyasa’s deep learning expertise to Certara products will enable our clients to expand how…Certara2023 年 3 月 10 日
What you should know about FDA Project Optimus for your oncology drug approval On-Demand Webinar 关于 FDA Project Optimus,您应该了解哪些有关肿瘤药物审批的信息 一直以来,肿瘤药物的剂量策略都以最大耐受剂量为重点。This…Danielle Pillsbury2023 年 3 月 10 日